Search Contract Opportunities

FDA Adverse Events Reporting System (FAERS) Data Management Program (DMP) Support Services   2

ID: 75F40123R00015 • Type: Synopsis Solicitation

Description

The U.S. Food and Drug Administration (FDA) intends to award an Indefinite Delivery-Indefinite Quantity (IDIQ) type contract with a 5-year ordering period, for the contractor to process FDA Adverse Event Reporting System (FAERS) reports, submitted by the public, by entering and coding the reports in a timely manner. This process is critical to ensure that the data can be reviewed by the FDA safety evaluation team to identify safety issues and respond to public health incidents to meet its regulatory mission. As a result, the FAERS data management services are required to achieve the results as follows: (1) Collect, receive and process mandatory and voluntary safety reports to make it available to the FDA Safety Evaluation Teams; (2) Establish quality assurance and training programs for the data entry process and management of coding services to enhance the quality of data for the FDA review and analysis; (3) Ongoing review of case processing activities for process improvement and program efficiency. The contractor shall perform these functional DMP services as follows:

  1. Performing services within the FDA Standard Operating Procedures (SOP) requirements.
  2. Development and enhancement of SOPs.
  3. Program management services for the oversight of data management operations, contractor staff training, records management, courier services and regular metrics reports.
  4. Receiving data in a variety of physical and electronic formats.
  5. Scanning physical documents into electronic formats, reviewing electronic submissions, and making the required corrections.
  6. Entering, registering, and processing data into the FDA computer system.
  7. Performing data analysis on case processing metrics, tracking services, and stakeholder/user support.
  8. Sorting and routing this data to the correct work area or correct FDA Center that regulates the product described.
  9. Medical coding of reports using various taxonomies (e.g., MedDRA).
  10. Performing quality assurance and quality control on data.
  11. Participating in the testing and validation of new software systems used to support new and more efficient data entry systems.

Overview

Response Deadline
Jan. 25, 2023, 3:00 p.m. EST (original: Jan. 20, 2023, 3:00 p.m. EST) Past Due
Posted
Jan. 4, 2023, 5:45 p.m. EST (updated: Jan. 19, 2023, 2:26 p.m. EST)
Set Aside
8(a) (8A)
Place of Performance
Silver Spring, MD 20993 United States
Source
SAM

Current SBA Size Standard
$40 Million
Pricing
Likely Fixed Price
Est. Level of Competition
Low
Vehicle Type
Indefinite Delivery Contract
Signs of Shaping
87% of obligations for similar contracts within the Food and Drug Administration were awarded full & open.
On 1/4/23 Food and Drug Administration issued Synopsis Solicitation 75F40123R00015 for FDA Adverse Events Reporting System (FAERS) Data Management Program (DMP) Support Services due 1/25/23. The opportunity was issued with a 8(a) (8A) set aside with NAICS 518210 (SBA Size Standard $40 Million) and PSC R617.
Primary Contact
Name
Nicholas Bisher   Profile
Phone
(240) 402-2773

Secondary Contact

Name
James G. Whitt   Profile
Phone
(240) 402-7627

Documents

Posted documents for Synopsis Solicitation 75F40123R00015

Question & Answer

Opportunity Lifecycle

Procurement notices related to Synopsis Solicitation 75F40123R00015

Protests

GAO protests filed for Synopsis Solicitation 75F40123R00015

Incumbent or Similar Awards

Contracts Similar to Synopsis Solicitation 75F40123R00015

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation 75F40123R00015

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation 75F40123R00015

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Sept. 30, 2023
Last Updated By
nicholas.bisher@fda.hhs.gov
Archive Date
Sept. 30, 2023